Benzodiazepines (BZs) allosterically modulate g-aminobutyric acid type-A receptors (GABA A Rs) to increase inhibitory synaptic strength. Diazepam binding inhibitor (DBI) protein is a BZ site ligand expressed endogenously in the brain, but functional evidence for BZ-mimicking positive modulatory actions has been elusive. We demonstrate an endogenous potentiation of GABAergic synaptic transmission and responses to GABA uncaging in the thalamic reticular nucleus (nRT) that is absent in both nm1054 mice, in which the Dbi gene is deleted, and mice in which BZ binding to a3 subunit-containing GABA A Rs is disrupted. Viral transduction of DBI into nRT is sufficient to rescue the endogenous potentiation of GABAergic transmission in nm1054 mice. Both mutations enhance thalamocortical spike-and-wave discharges characteristic of absence epilepsy. Together, these results indicate that DBI mediates endogenous nucleus-specific BZ-mimicking (''endozepine'') roles to modulate nRT function and suppress thalamocortical oscillations. Enhanced DBI signaling might serve as a therapy for epilepsy and other neurological disorders.
INTRODUCTION
Allosteric modulation can profoundly regulate the function of ion channels and G protein-coupled receptors in either a positive or negative direction (Conigrave and Franks, 2003; Schwartz and Holst, 2007) and is of increasing interest for both physiology and pharmacology. Benzodiazepines (BZs) act as allosteric modulators on type-A receptors for the inhibitory neurotransmitter g-aminobutyric acid (GABA). BZs act as either positive allosteric modulators (PAMs) and prolong currents through GABA A Rs to increase the duration and strength of inhibitory signals, or as negative allosteric modulators (NAMs, or inverse agonists) (Sieghart, 1995) . The discovery of BZ sites on GABA A Rs (Braestrup and Squires, 1977; Mö hler and Okada, 1977; Gavish and Snyder, 1980) led to the hypothesis that the brain might synthesize its own endogenous BZ site ligands (Iversen, 1977) . In the intervening years, however, functional evidence for endogenous PAM effects has been quite elusive.
The family of peptides derived from the 10 kDa protein diazepam binding inhibitor (DBI) (Guidotti et al., 1983; Alho et al., 1985) , also known as acyl-CoA binding protein (ACBP) (Knudsen, 1991) , has been suggested to play such roles. Most evidence, however, has indicated NAM actions, such as facilitation of anxiety behaviors (Guidotti et al., 1983; De MateosVerchere et al., 1998) , increased aggression (Kavaliers and Hirst, 1986) , and decreased sleep (Dong et al., 1999) . DBI and a DBI fragment peptide, octadecaneuropeptide (ODN), also promote neurogenesis in the subventricular zone (SVZ) via negative modulation of GABA signaling (Alfonso et al., 2012) . DBI is synthesized by both neurons and glia (Alho et al., 1989) , and its proteolytic peptide products bind to both GABA A R and mitochondrial BZ sites (Papadopoulos et al., 1991) . Functional evidence for endogenous PAM actions that would suppress neural excitability, however, has not been demonstrated.
Absence seizures, which are characterized by staring spells and brief lapses of consciousness that occur hundreds of times per day, are driven by abnormal oscillatory activity in thalamocortical (TC) networks (Crunelli and Leresche, 2002; Beenhakker and Huguenard, 2009 ). The thalamic reticular nucleus (nRT) is functionally and anatomically poised to play a critical gating role in this circuitry, which is normally involved in sleep rhythms and sensory processing (Steriade et al., 1993) . nRT receives excitatory input from both corticothalamic and TC axons and provides GABAergic input onto TC relay cells in dorsal thalamus, such as the ventrobasal nucleus (VB), as well as intranuclear inhibition via recurrent collaterals (Cox et al., 1996; Pinault et al., 1997; Shu and McCormick, 2002) . Reductions in intranRT inhibition result in hypersynchronous epileptiform oscillations between nRT and VB and promote absence seizures (von Krosigk et al., 1993; Huguenard and Prince, 1994a; Huntsman et al., 1999; . Conversely, a gain of intra-nRT inhibition dampens oscillatory duration and power (Schofield et al., 2009 ). Modulation of intra-nRT inhibition can thus shape TC circuit activity, thereby influencing seizure susceptibility and duration.
In mature nRT, the predominant GABA A R a subunit is a3, whereas a1 is highly expressed in dorsal thalamus (Wisden et al., 1992; Fritschy and Mohler, 1995) . Experiments utilizing mice bearing point mutations in either a3 (a3[H126R]) or a1 subunits (a1 [H101R] ) that selectively abolish BZ binding in GABA A Rs containing these subunits (Rudolph et al., 1999; Lö w et al., 2000) demonstrated that BZs act via specific enhancement of intranRT inhibition to suppress TC oscillations . A human GABA A R g2 subunit mutation that alters BZ binding is associated with absence seizures (Wallace et al., 2001) , suggesting a role for a PAM in regulating seizure activity, but this mutation also affects receptor trafficking (Kang and Macdonald, 2004) and GABA deactivation and desensitization kinetics (Bowser et al., 2002) .
DBI mRNA is widely expressed throughout the brain, including the thalamus (Lein et al., 2007) . Previous immunohistochemical studies have observed varying profiles of protein expression for DBI and fragment peptides in the CNS of various species (Tonon et al., 1990; Slobodyansky et al., 1992; Lihrmann et al., 1994) , likely due to use of different antisera and other methodological differences, but in some cases higher expression was observed in nRT (Alho et al., 1985 (Alho et al., , 1989 . We therefore hypothesized that DBI may exert endogenous effects within the thalamus, thereby modulating seizure susceptibility. Here, we investigate this by comparing inhibitory transmission, effects of BZ site blockade, and seizure profiles in wild-type (WT), a3(H126R), and nm1054 (new mutation 1054) mice, which harbor a 400 kb deletion on chromosome 1 that includes the Dbi gene (Ohgami et al., 2005 ). Furthermore, we tested the ability of viral transduction of DBI into the thalamus to rescue the effect of the nm1054 mutation. We also examine allosteric modulation of responses to focal GABA uncaging in ''sniffer'' patches pulled from VB neurons and placed back in the slice in either VB or nRT. Our results provide novel functional evidence for the constitutive presence of endogenous BZ binding site ligands (''endozepines'') that mimic the PAM actions of BZs specifically within nRT.
RESULTS

IPSC Duration in nRT Is Reduced in a3(H126R) Mutant Mice
The primary PAM effect of BZs on GABA A Rs is to increase the duration of inhibitory postsynaptic currents (IPSCs) . Therefore, we focused on this parameter in assessing whether endogenous BZ site PAMs alter intrathalamic inhibition. We recorded spontaneous IPSCs (sIPSCs) and evoked monosynaptic intra-nRT IPSCs (eIPSCs) in nRT cells from (H) Averaged uncaged IPSC traces for nRT patches from WT (black trace, n = 8 patches) and a3(H126R) mutant mice (blue trace, n = 5 patches) at P21. hn symbol indicates time of 1 ms UV laser stimulus. (I and J) Mean + SEM for uncaged IPSC half width (I; p > 0.5) and 90%-10% decay time (J; p > 0.3). Note that in contrast to the sniffer patch experiments presented in Figure 5 , here the patches were positioned in the superfusion solution > 100 mm above the slice to eliminate the influence of endogenous modulators. **p < 0.01, ***p < 0.001 versus WT. See also Figure S1 and Table S1. C57BL/6 WT and a3(H126R) mice. As in previous reports (Huntsman and Huguenard, 2000) , sIPSC duration progressively decreased through early development, reaching maturity by P20; therefore, all experiments used age-matched comparisons. a3(H126R) cells in both young and adult mice showed briefer sIPSCs (p < 0.001) and eIPSCs (p < 0.01) compared to WT (Figures 1A-1D and S1 ; Table S1 ). The decay phase of sIPSCs could be best described by a double exponential function, and both fast and slow decay time constants were shortened by the a3(H126R) mutation, while the relative contribution of fast and slow decay was unaffected (Table S1 ). This suggests that both components of IPSC decay are dependent on BZ-sensitive GABA A Rs. There was no difference in unitary conductance or numbers of channels mediating events as revealed by nonstationary variance analysis (Sigworth, 1980; De Koninck and Mody, 1994; Schofield and Huguenard, 2007; Figures 1E-1G) . Outside-out membrane patches pulled from WT and a3(H126R) cells showed similar responses to laser photolysis of caged GABA (1 mM) ( Figures 1H-1J ), indicating that differences in sIPSC duration are not due to altered GABA affinity or chloride conductance, but rather are due to the modulatory actions of a constitutively released BZ site PAM.
Flumazenil Reduces IPSC Duration in nRT, but Not VB To test the hypothesis that in WT mice an endogenous BZ site PAM constitutively potentiates IPSC duration, we examined the effect of 10 min bath application of flumazenil (FLZ, 1 mM), a BZ site antagonist (Hunkeler et al., 1981) . FLZ reduced sIPSC (p < 0.001) and eIPSC (p < 0.05) duration, along with decay rates, in WT nRT cells (Figures 2A-2E ; Table S1 ) but had no effect on sIPSC duration in a3(H126R) cells ( Figures 2F and 2G ), confirming that these effects depend on the BZ site on the a3 subunit.
BZs and DBI-derived peptides can increase the production of neurosteroids via upregulation of the mitochondrial BZ receptor, also known as peripheral BZ receptor (PBR) or 18 kDa translocator protein (TSPO) (Papadopoulos et al., 1991; Tokuda et al., 2010) . To examine if the FLZ-sensitive potentiation of sIPSCs reflect actions of neurosteroids, we used the 5a-reductase inhibitor finasteride (1 mM) to block neurosteroidogenesis. Finasteride alone reduced nRT sIPSC duration, indicating a level of constitutive neurosteroid expression ( Figures 3A and 3B ), but did not affect the response to FLZ, indicating that FLZ-induced reductions in sIPSC duration do not reflect blockade of neurosteroid actions ( Figures 3C and 3D) .
The degree of constitutive BZ site activation in nRT was estimated at $60%, based on the maximal modulation produced by a saturating concentration (100 nM) of clonazepam (CZP) (G) sIPSC half width in a3(H126R) nRT cells (n = 10) before (Con) and during FLZ treatment at P4-14. Open boxes indicate mean ± SEM. *p < 0.05, ***p < 0.001 versus con. See also Figure S2 and Table S1 . (Gibbs et al., 1996; Figures 4A-4D) . FLZ had no effect on VB cell sIPSCs (p > 0.2) (Figures 2A-2C and S2) but reversed the effects of CZP (Figures 4E and 4F) , indicating that VB neurons do respond to FLZ, but only in the presence of exogenous BZs; i.e., endogenous BZ site PAMs are not functionally active in VB.
Dbi Gene Products Mediate Endogenous BZ-Mimicking Actions in nRT One molecular candidate that may mediate the endogenous PAM effects in nRT is DBI. To test the role of DBI in mediating these effects, we compared nm1054 mice to WT littermates. Immunocytochemical staining confirmed that DBI protein expression in the thalamus is essentially abolished in nm1054 mice (Figures 5A and 5B) . As with the a3(H126R) mutation, the duration, charge transfer, and fast and slow decay time constants of sIPSCs in nRT cells from nm1054 mice was reduced compared to WT (p < 0.001) (Figures 5C and 5D; Table S2 ). These results suggest that loss of the Dbi gene reduces endogenous allosteric potentiation of GABAergic currents in nRT. To determine whether this deficit in the nm1054 mutant was due to loss of Dbi gene products, we tested the effect of infecting nRT cells with an AAV vector expressing DBI and green fluorescent protein (GFP) ( Figure S3 ). Injection of AAV-DBI-GFP into nRT of nm1054 mice both increased sIPSC duration and conferred responsiveness to FLZ treatment that was not observed in nm1054 mice injected with control AAV-GFP ( Figures 5E-5K ). Injection of AAV-GFP into WT nRT was confirmed to not affect responsiveness to FLZ (Figures 5I-5K ). Thus the endogenous PAM actions in nRT are mediated by products of the Dbi gene.
GABA Uncaging Responses in Sniffer Patches Pulled from VB Neurons Demonstrate nRT-Dependent Potentiation
The nucleus-specificity of FLZ effects may result from differential localization of PAMs and/or different GABA A R subunit composition in nRT and VB. To test these possibilities directly, we pulled outside-out membrane patches containing GABA A Rs from VB cells, which were then placed back into the slice to function as ''sniffer patches'' (Isaacson et al., 1993; Allen, 1997; Banks and Pearce, 2000) . We then tested the response (I) Probability distributions (>800 events/group) comparing sIPSC half width. (J) sIPSC half width in nRT cells from WT mice injected with control AAV-GFP (left, n = 7 cells), and nm1054 mice injected with AAV-GFP (middle, n = 7) or AAV-DBI-GFP vector (right, n = 11) before (Con) and during FLZ treatment. Open boxes indicate mean ± SEM. (K) Mean + SEM for percentage change in sIPSC half width in response to FLZ. Calibration: 100 mm (A and B); 200 mm (E); 25 mm (F-H). **p < 0.01, ***p < 0.001 versus WT (D, I, and K) or Con (J); ##p < 0.01, ###p < 0.001 versus nm1054 AAV-DBI-GFP (I and K). See also Figure S3 and Table S2. of these patches to laser photolysis of caged GABA (100 mM) when placed $25-50 mm deep into the slice in either VB or nRT ( Figure 6 ).
In WT slices, sniffer patches moved to nRT exhibited an increased uncaged IPSC duration compared to patches placed in VB (p < 0.00001) ( Figure 6A ). Both FLZ treatment and the nm1054 mutation largely blocked the nRT-dependent potentiation ($25% enhancement remaining in FLZ or nm1054 versus 72% in control, p < 0.01), and FLZ had no effect on responses in nm1054 slices (p > 0.9), suggesting that the nm1054 mutation removes a source of potentiating actions at BZ sites. This was confirmed further by occlusion of the nRT-dependent potentiation to a similar degree ($13% potentiation remaining) by the presence of CZP (Figures S4A and S4B ). Combined application of GABA transporter (GAT) antagonists and FLZ in WT slices blocked all nRT-dependent potentiation (p > 0.9), which was preserved in the presence of GAT antagonists alone (p < 0.001) (Figures S4C-S4E) , demonstrating that the residual potentiation in the presence of FLZ/CZP and in nm1054 mutants results from tissue-dependent differences in GABA uptake. Dbi gene products that are endogenous PAMs are thus constitutively released and bind to the extracellular BZ binding domain on GABA A receptors in nRT, but not VB. Furthermore, a1-containing GABA A Rs in VB are sensitive to endogenous PAMs (i.e., these actions do not depend on a3 subunits per se) but do not normally respond to FLZ treatment due to the absence of endogenous ligand in this nucleus.
Altered Spike-and-Wave Discharge Activity in a3(H126R) and nm1054 Mice Intra-nRT inhibition plays a critical role in regulating thalamic oscillations and absence seizure activity in the thalamocortical circuit. To examine whether the endogenous PAM actions observed in nRT modulate seizure susceptibility, we performed electroencephalogram (EEG) recordings in adult mice and assessed both spontaneous and pharmacologically induced spike-and-wave discharges (SWDs, a characteristic of absence epilepsy). SWDs in human absence epilepsy patients typically display $3 Hz internal frequency (Steriade et al., 1993; Crunelli and Leresche, 2002) , but in many rodent models the internal frequency is in the range of 4-6 Hz (Noebels and Sidman, 1979; Ryan and Sharpless, 1979; Hosford et al., 1992) . Both a3(H126R) and nm1054 mice showed a higher incidence of spontaneous 4-6 Hz SWDs compared to the very rare events in WT counterparts (p < 0.01; Figures 7A-7D) , suggesting a level of constitutive BZ site activation that is antiepileptic.
Low dose pentylenetetrazol (PTZ) is a common means of chemically inducing absence seizures and SWD in rodents (Snead, 1998) . In WT and a3(H126R) mice on the C57BL/6 background, however, PTZ induced generalized tonic-clonic seizures rather than absence seizures, precluding examination of strain-dependent differences in SWDs (see Supplemental Information). Therefore, we also examined a3(H126R) mutants on the 129X1/SvJ background, which we found to be less susceptible to tonic-clonic seizures. In this strain, experimental absence seizures initiated rapidly and were characterized by prominent $4-5 Hz SWDs that peaked approximately 5 min after injection, reaching a similar peak incidence in both genotypes, but persisted at a much higher rate over time in the a3(H126R) mutants ( Figure S5 ). SWD internal frequency showed a progressive slowing from $4 to 3 Hz during the course of repeated seizures in WT, but remained constant at $5 Hz in a3(H126R) mutants (p > 0.8) (Figures 7E and 7G) . Similarly, nm1054 mice failed to display the slowing of SWD internal frequency following PTZ injection (p > 0.6) that was observed in WT ( Figures 7F and  7H ). These results suggest that PAM release within the TC circuit reduces seizure susceptibility and severity through a slowing of the seizure oscillations, which may destabilize them.
DISCUSSION
Following the discovery of BZ binding sites on GABA A Rs 35 years ago (Braestrup and Squires, 1977; Mö hler and Okada, 1977; Gavish and Snyder, 1980) , it was thought that the brain likely produces cognate endogenous ligands for these sites. In the intervening years, however, the search for an endogenous PAM proved elusive. The studies presented here provide functional evidence for endogenous BZ-mimicking (''endozepine'') PAM actions and indicate that these effects are mediated by Dbi gene products. This was demonstrated by the deficits in IPSC potentiation exhibited in nm1054 mice, which was rescued by local viral transduction of DBI into nRT. Although the PAM effects in nRT depend on the a3 subunit BZ binding site, as demonstrated by the lack of modulation in a3(H126R) mice, GABA A Rs in VB neurons respond to endozepines when placed in nRT. This indicates that the nucleus specificity of the observed effects results from nRT-specific localization of PAMs within the thalamus. Finally, we present in vivo evidence that SWD activity is altered in both a3(H126R) and nm1054 mice, suggesting that local PAM actions in nRT can exert seizure-suppressive effects on TC circuitry as a whole. Although it remains to be determined whether DBI itself or a peptide fragment act as the BZ site agonist, our data provide functional evidence that indeed peptides in the DBI family can act as PAMs.
Constitutive Endogenous Positive Allosteric Modulation of GABAergic Transmission by Endozepines in nRT
The principal findings of this study are the existence and functional consequences of endozepines in nRT, which act to potentiate GABAergic postsynaptic currents in this nucleus. a3(H126R) mutant mice, in which classical BZ binding to the GABA A R a3 subunit is effectively abolished (Lö w et al., 2000) , exhibited shorter durations of both sIPSCs and eIPSCs, indicating that in WT mice, constitutive modulation via this binding site acts to prolong inhibitory signals. Another GABA A R mutation associated with BZ binding and absence seizures (Wallace et al., 2001 ) has been reported to affect basic receptor . Note that SWD amplitude (power) was not significantly different between groups (p > 0.2). Therefore, examples were chosen to illustrate typical SWD waveforms in each condition, which were not affected by SWD power. (C and D) Mean + SEM for spontaneous 4-6 Hz SWD rate and percentage of time spent in spontaneous SWD activity in WT (n = 17) and a3(H126R) mice (n = 9) (C) and WT (n = 7) and nm1054 mice (n = 4) (D). (E and F) Mean ± SEM for SWD period over time following PTZ injection (Time 0, 40 mg/kg) in WT (n = 7) and a3(H126R) mice (n = 4) (E) and WT (n = 7) and nm1054 mice (n = 4) (F). (G and H) Linear regression of lines of best fit for points plotted in (E-F) shows positive correlations (i.e., SWD slowing) with time after PTZ injection in WT, but not in a3(H126R) nor nm1054 mice. **p < 0.01, ***p < 0.001 versus WT; ##p < 0.01, ###p < 0.001, repeated-measures ANOVA (E and F) or Pearson correlation (G and H) across 1 min bins after PTZ injection. Gray bars in (E) and (F) indicate times at which values differed between mutants and controls (p < 0.05). See also Figure S5 .
properties such as receptor trafficking and expression and response to GABA (Bowser et al., 2002; Kang and Macdonald, 2004) . Here, the effects of the a3(H126R) mutation on sIPSCs were confined to the duration of events, with no difference in either amplitude or frequency; thus it does not appear that this mutation leads to large differences in receptor expression, localization, or function besides the loss of BZ or endozepine binding. Both fast and slow decay time constants were reduced, suggesting that both b1 and b3 subunit-containing receptors in nRT are responsive to endozepines (Huntsman and Huguenard, 2006; Hentschke et al., 2009) . Furthermore, when nRT GABA A Rs in excised patches were removed from the slice and thus no longer exposed to putative endogenous modulators within the slice, the response to GABA uncaging was identical between WT and a3(H126R) mutant mice. Together, these results support the interpretation that the H126R mutation does not lead to differences in fundamental receptor properties apart from the effects on BZ/endozepine binding in a3(H126R) mutant receptors.
The ability of FLZ, a BZ binding site antagonist (Hunkeler et al., 1981) , to reduce sIPSC duration also suggested an endogenous augmentation of IPSC duration in nRT. Similarly, FLZ has been observed to reduce evoked inhibitory postsynaptic potential (IPSP) amplitude in hippocampal CA1 pyramidal neurons (King et al., 1985) and eIPSC duration in dissociated cortical neurons (Vicini et al., 1986) . Some reports have indicated agonist effects of FLZ (Skerritt and Macdonald, 1983; De Deyn and Macdonald, 1987; Weiss et al., 2002) , including at receptors carrying a3 subunits (Ramerstorfer et al., 2010) . This would not explain the reductions in duration and decay time observed here, although FLZ increased sIPSC amplitude and slightly increased charge transfer in both WT and a3(H126R) nRT cells, potentially indicating a nonspecific effect representing actions on presynaptic terminals (Table S1 ). Partial agonistic effects of FLZ have also been described at receptors containing a4 or a6 subunits (i.e., receptors that do not respond to classical BZs) (Hadingham et al., 1996; Knoflach et al., 1996; Whittemore et al., 1996) . Here, however, a3(H126R) GABA A Rs did not respond to FLZ, indicating that disruption of BZ binding to these receptors does not change the direction of response to BZ binding site activation.
A recent report indicates that the CSF of hypersomnolent patients can potentiate currents evoked by GABA application in a FLZ-sensitive manner (Rye et al., 2012) . This potentiation, however, is not occluded by the BZ midazolam and persists in a1(H101R) GABA A Rs, indicating that it does not represent a true BZ-mimicking endozepine effect.
Dbi Gene Products Mediate Endozepine Effects in nRT
The experiments in a3(H126R) mice examined the potential effects of endozepines at the level of postsynaptic GABA A Rs. To investigate this question at the level of the ligand, we tested the role of Dbi gene products in mediating endozepine actions by exploring intra-nRT GABAergic transmission in nm1054 mice, which lack the Dbi gene (Ohgami et al., 2005) . The other known genes deleted by the mutation are: primary ciliary dyskinesia protein 1 (Pcdp1); secretin receptor (Sctr); neuronal voltage-gated calcium channel g-like subunit (Pr1); and sixtransmembrane epithelial antigen of the prostate 3 (Steap3) (Ohgami et al., 2005; Lee et al., 2007) . Pr1 transcript is either absent or very low in mouse thalamus (Lein et al., 2007) . The other genes are not expected to affect postsynaptic GABA A receptor function, though the secretin peptide may act on presynaptic terminals to increase GABAergic transmission in cerebellum (Yung et al., 2001 ). Although future work will examine the role of DBI using a specific knockout model, nm1054 mice injected with the AAV-DBI vector in nRT displayed the following effects: (1) prolonged sIPSC duration compared to nm1054 mice injected with control virus, and (2) a reduction in sIPSC duration in response to FLZ that was not observed in nm1054 mice injected with control virus and is of the same magnitude as that observed in WT mice. DBI is thus necessary and sufficient to produce the endogenous PAM effect, and is either the endogenous modulator itself or at least a precursor.
These results stand in contrast to the majority of previous studies of DBI-related peptides, which have primarily found NAM effects. Application of DBI reduced the amplitude of GABA currents recorded in cultured spinal cord neurons (Bormann et al., 1985; Macdonald et al., 1986) , as did ODN application to nucleated outside-out patches from SVZ progenitor cells (Alfonso et al., 2012) . A NAM effect, however, would be disinhibitory and would not explain the endogenous potentiation observed here. Of note, these studies used high concentrations (0.5-20 mM) of applied peptide. Effects of exogenous DBI peptides on seizures exhibit dose-dependent effects, with low doses being efficacious at suppressing seizures (Garcia de MateosVerchere et al., 1999) and high doses promoting seizure activity (Ferrero et al., 1986) . It is also possible that nRT-specific receptor-associated proteins are required to obtain a PAM effect, though this is unlikely to be solely responsible as VB receptors placed in nRT also exhibit a PAM response, as demonstrated in the sniffer patch studies (Figure 6 ). In addition, the dose response curve for stimulation of intracellular calcium levels in cultured astrocytes by ODN and octapeptide (OP), a smaller fragment, is bell-shaped with peak stimulation at 10 nM . Therefore, it is possible that extracellular concentrations of endogenous DBI peptides in discrete areas such as nRT are at a lower level that is more likely to exert PAM rather than NAM effects.
In contrast to the stark nRT versus VB differences in physiological PAM effects of DBI, immunoreactivity to DBI was observed in both nRT and VB ( Figure 5 ). In this regard, it is important to note that DBI is also known as ACBP and the Dbi/Acbp gene is thought to ubiquitously serve housekeeping functions (Knudsen et al., 1993) , generating an intracellular protein critically involved in facilitating intracellular transport of Acyl-CoA. We hypothesize that the nRT versus VB differences in the electrophysiological findings likely represent nucleus-specific differences in the extracellular release and processing of DBI.
In the current studies, we used a viral strategy to examine whether Dbi gene products are necessary and sufficient to produce endozepine actions in nRT. Although it is possible that viral introduction of DBI into a system in this way induces changes in its modulatory effects, it is unlikely that this explains the PAM actions observed here, as a recent report using similar viral vectors to express DBI and ODN in the SVZ exclusively observed NAM effects (Alfonso et al., 2012) . The mechanism(s) underlying these differences remain to be determined, though one possible explanation is differential intra-or extracellular processing of DBI, the nature of which is specific to certain areas or cell types. It is certainly conceivable that some DBI fragments exert PAM effects, whereas others are NAMs. In addition, preliminary evidence suggests that exogenous application of DBI does not alter sIPSCs in VB (C.A.C. and J.R.H., unpublished data), in contrast to the robust potentiation of uncaging responses when VB sniffer patches are placed in nRT. This further supports a working model in which nRT-specific processing of Dbi gene products underlies the PAM actions.
Functional Endozepines Are Absent in VB Strikingly, endogenous BZ-mimicking potentiation was observed in nRT, but not in adjacent VB thalamus. This raises the question of why such effects would be specifically localized to nRT, and not VB. Perhaps selection pressure led to evolution of an adaptive specific subcircuit modulation in nRT that reduces the possibility of seizure occurrence. Synaptic inhibition in nRT exerts a prominent desynchronizing effect to reduce the propensity for oscillatory activity (von Krosigk et al., 1993; Huntsman et al., 1999; Schofield et al., 2009) , and potentiation of synaptic inhibition by BZs further suppresses oscillations (Huguenard and Prince, 1994a; . In VB, by contrast, postsynaptic inhibition via GABA A and GABA B receptors interacts with prominent T-type calcium conductances in VB relay neurons to drive robust postinhibitory rebound burst firing (Lliná s and Jahnsen, 1982; Huguenard and Prince, 1994b; and paradoxically promote oscillatory activity. Therefore, endogenous potentiation of intra-nRT inhibition is poised to exert an endogenous antioscillatory seizure-suppressing effect, whereas such potentiation in VB could be disadvantageous. It should be noted, however, that VB neurons are BZ-sensitive, as demonstrated here and in previous studies (Oh et al., 1995; Peden et al., 2008) , although systemic treatment with BZs would influence both nRT and VB inhibition such that activity throughout the circuit would be globally suppressed. Indeed, constitutive activation in nRT was $60% of maximal, indicating that although there is a substantial degree of endogenous modulation, there is still an extent of enhancement that can be exploited by exogenous BZs, likely explaining the therapeutic efficacy of these drugs.
Focal GABA Uncaging on Sniffer Patches Reveals Nucleus-Specific Differences in Endozepine Potentiation and GABA Uptake Here, we introduce a methodology combining the ''sniffer patch'' recording configuration (Isaacson et al., 1993; Allen, 1997; Banks and Pearce, 2000) with laser GABA uncaging, which is used to examine nucleus-specific differences in endogenous BZ site modulation. The main advantage of this method is that GABA exposure to the patches can be normalized independent of patch placement, so that region-specific differences in modulation of GABAergic signaling can be assessed. Combined application of GAT antagonists and FLZ was sufficient to completely block the nRT-dependent potentiation. This potentiation is thus mediated in large part by endozepines, and to a lesser extent by nucleus-specific differences in rates of GABA uptake, with more robust uptake in VB than in nRT. This is consistent with the postulated role for GATs in removing GABA from VB extracellular space in order to prevent excessive GABA B R activation and oscillatory seizure activity (Beenhakker and Huguenard, 2010) .
The durations of uncaging responses for both nRT and VB patches are longer than those for spontaneous or evoked IPSCs, in accordance with previous studies on patches from thalamic, hippocampal, and cortical neurons (Galarreta and Hestrin, 1997; Jones and Westbrook, 1997; Banks and Pearce, 2000; Schofield and Huguenard, 2007) . Therefore, this appears to be an effect of the pulled patch configuration rather than the use of uncaging to apply GABA. Nevertheless, the application of GABA by laser photolysis replicates the nRT versus VB differences in receptor affinity for GABA and kinetics of IPSC decay (Zhang et al., 1997; Mozrzymas et al., 2007; Schofield and Huguenard, 2007) .
Endozepines Modulate TC Circuit Activity In Vivo Potentiation of intra-nRT GABAergic transmission by BZs is capable of exerting powerful antioscillatory effects by reducing synchronization in intra-thalamic networks (Huguenard and Prince, 1994a; Huguenard, 1999; . Similarly, the EEG recordings here indicate that PAM potentiation of GABAergic transmission, presumably within nRT as observed in vitro, can modulate in vivo rhythmic activity in TC circuitry in a manner consistent with suppression of seizure susceptibility and severity. In particular, both a3(H126R) and nm1054 mice exhibit similar phenotypes with respect to an increased incidence of spontaneous SWDs and a lack of slowing of SWD period following PTZ treatment that is observed in WT mice. This suggests that endogenous activation of BZ binding sites on GABA A Rs containing the a3 subunit by DBI ligands in nRT exerts two primary effects: (1) a reduction in the propensity for the circuit to generate SWDs, and (2) a reduction in the intensity and severity of absence seizures once initiated. Although the a3 subunit is expressed in other brain regions, including cortical layers V and VI (Pirker et al., 2000) , the complementary in vitro experiments implicate actions that originate in thalamus, and specifically in nRT, in underlying these differences.
Summary
Our results describe the molecular identification of an endogenous DBI-related PAM acting via GABA A R BZ binding sites, which may represent a novel endogenous anti-seizure mechanism. The highly specific release and processing within nRT (and presumably other restricted brain regions) may explain why previous studies using a3(H126R) and similar knockin mice have not observed overt phenotypes beyond those of subtype-specific BZ actions (Rudolph and Mö hler, 2004) . Given the important role of nRT as a locus of control in TC circuitry, targeted release of Dbi-derived endozepine peptides in nRT may be fruitful in the development of therapies against absence seizures. Furthermore, regulation of DBI release or function may provide a safer alternative to long-term BZ administration in the treatment of epilepsy and other neurological disorders.
EXPERIMENTAL PROCEDURES
Additional information on these methods can be found in Supplemental Information. All procedures were approved by the Administrative Panel on Laboratory Animal Care at Stanford University.
Brain Slice Preparation
Mice were anesthetized with pentobarbital sodium and killed via decapitation and the brain was quickly removed and placed in ice-cold oxygenated sucrose slicing solution. Horizontal thalamic slices (250 mm thickness) were prepared as previously described (Huguenard and Prince, 1994a) . Slices were incubated and continuously oxygenated in warm ($32 C) artificial cerebrospinal fluid for 1 hr and then transferred to room temperature ($21 C-23 C)
for at least 15 min prior to recording.
Patch-Clamp Electrophysiology
Patch-clamp recordings were made using a MultiClamp 700A amplifier with Clampex 9.2 software. Patch pipettes were filled with a 135 mM CsClbased solution. To isolate GABAergic IPSCs, ionotropic glutamate receptors were blocked with either kynurenic acid (1 mM) or a combination of D-(-)-2-amino-5-phosphonovaleric acid (APV, 100 mM) plus 6,7-dinitroquinoxaline-2,3-dione (DNQX, 20 mM).
IPSCs
In whole-cell recordings, membrane potential was clamped at À60 mV. Evoked IPSCs were elicited by extracellular tungsten electrode stimulation in nRT.
GABA Uncaging CNB-caged GABA (Invitrogen) was added to a recirculating 10-20 ml bath solution containing APV and DNQX. Outside-out patches of membrane from nRT or VB cells were maintained in voltage-clamp mode at a membrane holding potential of À30 mV. Laser photolysis (DPSS Lasers) was achieved via 1 ms ultraviolet laser exposure.
EEG Recordings
EEG recordings were obtained from either metal skull screws or silver wires implanted above the left and right frontal and parietal cerebral cortices. Experimental absence seizures were induced via s.c. injection of PTZ. EEG activity and simultaneous video were recorded for up to 90 min post-PTZ injection.
Virus Injections
Bilateral stereotaxic injections of either control or DBI-expressing AAVs were performed under isoflurane anesthesia between P48-60. Brain slices were prepared for electrophysiology at 2-3 weeks postinjection. Infected cells expressing GFP were visualized using epifluorescence microscopy.
Data Analysis sIPSCs were analyzed using the custom software programs wDetecta and WinScanSelect (J.R.H.). eIPSC and uncaging recordings were analyzed using Clampfit. EEG recordings were analyzed using a continuous wavelet transform method in MATLAB to isolate SWD events (Schofield et al., 2009) . Comparisons between groups were made using two-tailed independent or paired t tests, nonparametric Mann-Whitney rank-sum tests, or one-way ANOVA with Tukey's post hoc means comparison tests. Cumulative probability distributions were constructed using up to 100 randomly selected sIPSCs (events) per cell and compared using two-sample Kolmogorov-Smirnov (KS) goodness of fit tests. Differences within each genotype for EEG parameters across different time points after PTZ injection were assessed using one-way repeated-measures ANOVA. Statistical significance was set at p < 0.05 for means comparisons, and p < 0.001 for KS tests. 
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